Abstract:DRD1 is expressed in normal lung respiratory epithelial cells, and its expression is reduced in NSCLC tumor tissues at least partially through promoter methylation. In lung cancer cells, DRD1 signaling reduces proliferation through reduced EGFR signaling, and it also reduces PD‐L1 expression. Impaired DRD1 signaling has the opposite effect. Dopamine (DA) acts in various key neurological and physiological processes as both a neurotransmitter and circulating hormone. Over the past several decades, the DA signaling network has been shown to regulate the progression of several types of solid tumors, and considerable evidence has shown it is a druggable pathway in the cancer cell context. However, the specific activity and effect of these pathway components appears to be tissue‐type and cell‐context‐dependent. In the present study, expression and methylation of dopamine receptor D1 (DRD1) were measured using RNA sequencing (RNAseq) and reverse transcription polymerase chain reaction (RT‐PCR) in non‐small cell lung cancer (NSCLC) samples, and validated using publicly available datasets, including The Cancer Genome Atlas (TCGA). In vitro and in vivo functional experiments were performed for cell proliferation and tumor growth, respectively. Mechanistic analyses of the transcriptome and kinome in DRD1‐modulated cells informed further experiments, which characterized the effects on the epidermal growth factor receptor (EGFR) pathway and programmed cell death 1 ligand 1 (PD‐L1) proteins. Through these experiments, we identified the DRD1 gene as a negative regulator of disease progression in NSCLC. We show that DRD1, as well as other DA pathway components, are expressed in normal human lung tissue, and that loss of DRD1 expression through promoter hypermethylation is a common feature in NSCLC patients and is associated with worse survival. At the cellular level, DRD1 affects proliferation by inhibiting the activation of EGFR and mitogen‐activated protein kinase 1/2 (ERK1/2). Interestingly, we also found that DRD1 regulates the expression of PD‐L1 in lung cancer cells. Taken together, these results suggest that DRD1 methylation may constitute a biomarker of poor prognosis in NSCLC patients while other components of this pathway could be targeted to improve response to EGFR‐ and PD‐L1‐targeted therapies.

Downregulated in renal carcinoma 1 (DRR1) mediates the differentiation of neural stem cells through transcriptional regulation

Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.

N-myc Downstream Regulated Gene 1 Inhibition of Tumor Progression in Caco2 Cells.

Identification and Preliminary Function Study of Xenopus Laevis DRR1 Gene

Nssr1 Promotes Neuronal Differentiation of Mouse Embryonic Carcinoma P19 Cells

DRD1 suppresses cell proliferation and reduces EGFR activation and PD‐L1 expression in NSCLC

NDRG1 Contributes to Retinoic Acid-Induced Differentiation of Leukemic Cells.

The Downregulated Long Noncoding RNA DHRS4-AS1 is Protumoral and Associated with the Prognosis of Clear Cell Renal Cell Carcinoma.

Canonical Micrornas Enable Differentiation, Protect Against DNA Damage, and Promote Cholesterol Biosynthesis in Neural Stem Cells.

Down Syndrome Candidate Region 1 Isoform 1L regulated tumor growth by targeting both angiogenesis and tumor cells

MiR-196a-5p/NR6A1 Regulates All-Trans Retinoic Acid Induced Neural Differentiation of Hntera-2 Stem Cells Via E-Cadherin Inhibition

Downregulation of Long Noncoding RNA FENDRR Predicts Poor Prognosis in Renal Cell Carcinoma

Down Expression of LRP1B Promotes Cell Migration Via RhoA/Cdc42 Pathway and Actin Cytoskeleton Remodeling in Renal Cell Cancer

Identification of NDRG1-regulated genes associated with invasive potential in cervical and ovarian cancer cells.

Expression and Significance of N-myc Downstream Regulated Gene 1 in Renal Cell Carcinoma

Receptor-interacting Protein 140 Overexpression Promotes Neuro-2a Neuronal Differentiation by ERK1/2 Signaling

Identification and Distribution of Rrnh1, A Gene Upregulated after Spinal Cord Primary Neuron Injury

Identification of Down-Expressed CRNN Associated with Cancer Progression and Poor Prognosis in Laryngeal Squamous Cell Carcinoma

Microrna-1 Regulates NCC Migration and Differentiation by Targeting Sec63

SCIRR39 promotes neurite extension via RhoA in NGF-induced PC12 cells

DRAM1 Plays a Tumor Suppressor Role in NSCLC Cells by Promoting Lysosomal Degradation of EGFR